- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Early-stage Breast Cancer in Hungary
Total 198 results
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
PfizerCompletedEarly Breast CancerCzechia, Serbia, Slovakia, United States, Belarus, Hungary, Ukraine, Italy, Poland, Russian Federation
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
ETOP IBCSG Partners FoundationAlliance for Clinical Trials in Oncology; Canadian Cancer Trials Group; Breast...Active, not recruitingEarly Breast CancerKorea, Republic of, United States, France, Canada, Spain, Lebanon, Belgium, Switzerland, Israel, Ireland, Japan, Italy, Denmark, Austria, Australia, Greece, Hungary, Netherlands, Norway, Portugal, Serbia, Slovenia
-
AstraZenecaRecruitingBreast Cancer, Early Breast CancerUnited States, Canada, United Kingdom, China, Argentina, Australia, Hungary, Netherlands, Korea, Republic of, France, Germany, Italy, Belgium, Bulgaria, India, Mexico, Spain, Vietnam, Colombia, Japan, Peru, Brazil, Malaysia, Taiwan, Tha... and more
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Novartis PharmaceuticalsTranslational Research in OncologyActive, not recruitingEarly Breast CancerUnited States, Belgium, Canada, Italy, United Kingdom, Hungary, Taiwan, Australia, Germany, Spain, Austria, Russian Federation, Korea, Republic of, China, France, Brazil, Ireland, Argentina, Romania, Poland
-
Hoffmann-La RocheRecruitingEarly Breast CancerUnited States, France, Korea, Republic of, Spain, China, Italy, Taiwan, Sweden, Czechia, Hungary, Japan, Greece, Ukraine, Australia, Brazil, Canada, Mexico, Belgium, Argentina, Chile, Serbia, Colombia, Ireland, Hong Kong, Austria, North Macedonia and more
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, Canada, Poland, Portugal, United Kingdom, France, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Romania, ... and more
-
National Institute of Oncology, HungaryUnknownInvasive Breast Cancer | in Situ Breast CancerHungary
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
National Institute of Oncology, HungaryNot yet recruiting
-
National Institute of Oncology, HungaryCompleted
-
National Institute of Oncology, HungaryCompleted
-
Semmelweis UniversityRecruitingHER2-negative Breast CancerHungary
-
National Institute of Oncology, HungaryActive, not recruitingBreast Cancer | Radiation Toxicity | Side EffectsHungary
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Australia, Greece, Spain, United States, United Kingdom, France, Israel, Malaysia, Japan, Belgium, Poland, China, Germany, Czechia, Singapore, Hungary, Brazil, Italy, South Africa, Portugal, Argentina, Hong... and more
-
Central European Cooperative Oncology GroupCompletedBreast CancerAustria, Hungary, Poland, Slovakia
-
PfizerHospira, now a wholly owned subsidiary of PfizerCompletedNon-metastatic Breast CancerHungary, Spain
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Breast International GroupTerminatedBreast CancerSwitzerland, Italy, Hungary
-
AstraZenecaCompleted
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient SatisfactionHungary
-
Genzyme, a Sanofi CompanyCompletedAdvanced Breast CancerSouth Africa, Sweden, Hungary, Taiwan, Spain
-
ERYtech PharmaTerminatedTriple Negative Breast CancerSpain, Belgium, Hungary
-
Hoffmann-La RocheCompleted
-
Immutep S.A.S.CompletedAdenocarcinoma Breast Stage IVNetherlands, United Kingdom, France, Belgium, Germany, Hungary, Poland
-
Hoffmann-La RocheCompletedMetastatic Breast CancerHungary
-
University of Erlangen-Nürnberg Medical SchoolUnknownBreast CancerAustria, Germany, Hungary, Poland, Spain
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Mastectomy; LymphedemaHungary
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
National Institute of Oncology, HungaryRecruitingQuality of Life | Breast Cancer | Patient Satisfaction | Mastectomy; LymphedemaHungary
-
Prestige Biopharma LimitedCompletedHER2 Positive Breast CancerSpain, Malaysia, Estonia, Hungary, Thailand, Belarus, Bulgaria, France, Georgia, Italy, Poland, Russian Federation, Ukraine
-
Hoffmann-La RocheCompleted
-
Acrotech Biopharma Inc.CompletedBreast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary CarcinomaFrance, United States, Czechia, Hungary
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
-
Hoffmann-La RocheCompleted
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
Spanish Breast Cancer Research GroupPfizer; AstraZenecaCompletedMetastatic Breast CancerSpain, Israel, Hungary, Austria
-
Eli Lilly and CompanyCompletedBreast CancerBrazil, Greece, Hungary, Peru, Poland, Spain, Venezuela
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
Eli Lilly and CompanyCompletedBreast CancerAustria, Czech Republic, Hungary, Poland, Romania, Russian Federation
-
AstraZenecaCompleted
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownMetastatic Breast CancerKorea, Republic of, United Kingdom, Hungary, Georgia, France, Romania
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSpain, Switzerland, Hungary, France, Italy, Peru, Portugal, Sweden
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupRecruitingNode-positive Breast CancerGreece, Switzerland, Hungary, Austria, Germany, Italy, Lithuania, Argentina, Croatia